SEC Form 4 · accession 0001567619-18-007389
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 12:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Dec 3, 2018 | S | 600 | $112.09 | D | 83,689 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.